delia goletti

Infettivologa e ricercatrice presso l'Istituto Nazionale per le Malattie Infettive L.Spallanzani😷👩‍🔬

[Olivier Neyrolles @ONeyrolles]

Yet another fantastic #CTVD meeting!
@gatesfoundation⁩

[delia goletti @Deliagoletti2]

Interesting presentation by Chiara Farroni at #ESCMIDGlobal on immune memory response to #Mycobacterium #tuberculosis in #IMID patients from #Translational Research unit #INMI #spallanzani #IRCCS

[delia goletti @Deliagoletti2]

Interesting presentation by Elisa Petruccioli at #ESCMIDGlobal on immune memory response to MPXV from #Translational Research unit #INMI #spallanzani #IRCCS

[delia goletti @Deliagoletti2]

Wonderful #ESCMIDGlobal meeting in #Barcelona! Great opportunity to present my work, outstanding lectures, possibility for #INMI #IRCCS #Spallanzani for new interactions!

[Seif Al-Abri @AbriSeif]

We're pleased to contribute & share this new research on latent tuberculosis (LTBI) screening in migrants for #WorldTBDay! ➡️ https://t.co/XpHoJwqjsJ
Take-home messages:
Diagnosing LTBI in migrants is complex
Screening & preventive treatment are key
More research needed on effective screening programs
#PublicHealth #Tuberculosis #IJID @ISID

[delia goletti @Deliagoletti2]

It is important to invest in Research against #TB. In a special issue of the International Journal of Infectious Diseases, published by @ISID, some new aspects on the fight against TB are reprted. ➡️ https://t.co/ydSI06ZZMV… #PublicHealth #Tuberculosis #IJID

[TB Alliance @TBAlliance]

Investing in #TB R&D is not just imperative to advancing the prevention, diagnosis, treatment, and care of #tuberculosis, it's also a smart investment in #globalhealth. Join partners around the world to raise awareness this #WorldTBDay: https://t.co/TqPPkgQqr4 #YesWeCanEndTB

[Seif Al-Abri @AbriSeif]

Today is #WorldTBDay & we're saying #YesWeCanEndTB! 💪 This special issue of the International Journal of Infectious Diseases, published by @ISID, discusses the ongoing fight against TB. ➡️ https://t.co/IqG5WV88Rh #PublicHealth #Tuberculosis #IJID

[il badante di valico @luigicodecasa]

While celebrating World TB Day 2024, we need to improve the the testing and the access to drugs in many European countries @StopTbItalia @FerrareseMauri1 @Nanni_Sotgiu @Deliagoletti2 @AlibertiStefano @edo_simonetta @RiccardiNiccolo @M_Raviglione @maura_spotti

[delia goletti @Deliagoletti2]

For the 2024 World TB Day, IJID prepared a special issue to highlight prectices and innovations in tuberculosis. https://t.co/SDFbSwI2QK

[emanuele nicastri @manuelenicastri]

21 malattie sconosciute, senza ricerca, senza cure, senza vaccini. Legate a conflitti, povertà e cambi climatici, tutte sulle spalle della gente più povera tra i poveri. Ecco oggi è la festa delle malattie tropicali dimenticate. 30.01.24. @ntd @INMISpallanzani @WHO @ISSalute_it

[delia goletti @Deliagoletti2]

Yes! We Can #EndTB!” is the #WHO and #STOP TB Partnership theme for #worldtbday 2023. In this special #IJID World TB Day issue we present 9 reports covering issues to consider to #End TB, as  #vaccines, #MDR-TB management, preventive therapy, #COVID-19/TB https://t.co/NjOGMvn9gj

[delia goletti @Deliagoletti2]

@chetempochefa Geniale il paragone di Serra tra il diritto legale di viaggio delle merci a livello globale rispetto alla assenza totale di diritto di viaggio degli esseri umani che provengono dalle parti più disagiate del mondo. Grazie.

[il badante di valico @luigicodecasa]

3* Seminario su TB e NTM a Villa Marelli. 20 partecipanti. Top Speakers. #EndTB #NTM @Nanni_Sotgiu @FerrareseMauri1 @AlibertiStefano @registro_irene @GiorgioPol @StopTbItalia @Deliagoletti2 @RiccardiNiccolo @BindoFrancesco @NicolaIvanLore

[delia goletti @Deliagoletti2]

Honored to be part of the faculty of the #ESCMID Summer School and talk on challenges in #tuberculosis treatment. Very talented students from worldwide that bring curiosity, intelligence, freshness. And to defeat #tuberculosis and #endTB, we are all needed and called to action.

[Trainee Association of ESCMID @TAEscmid]

🫁 There are still challenges in tuberculosis treatment - an exciting presentation by @Deliagoletti2 @ESCMID Summer School
👉 we need to"reimagine"our
research response to TB and bring TB research into the 21st century

[Immunology of Infectious Disease News @infdisease_news]

🔎 Led by Dr. @DeliaGoletti2, scientists at the National Institute for Infectious Diseases in Italy found that #cysteamine exerts in vitro antiviral activity against the #SARSCoV2 Delta and #Omicron variants.

@cddpress: https://t.co/ZUHPGJ6CTt

[delia goletti @Deliagoletti2]

Wonderful experience to work with the #ECIL group on the #guidelines on #Mycobacterial infections in adults with haematological #malignancies and haematopoietic stem cell #transplants, now published on Lancet Infectious Diseases. https://t.co/PBdk6oF3yq

[TBnet @TBnet_EU]

Networks statement: Lack of access to rifapentine in Europe denies patients optimal care for active tuberculosis & latent tuberculosis infection @TBnet_EU @EuroRespSoc ESGMYC @ESCMID @FlorianPMaurer @gglond @FvLScience @RaquelAFDuarte @Deliagoletti2 @SimonTiberi @ChristophLange

[Eurosurveillance @Eurosurveillanc]

@sal_hargreaves @hayward_sally @StopTB @IDarkbell @TeyNoori @Deliagoletti2 @DrCGreenaway Screening for latent TB infection including migrants
🔸was reported for 15 countries
🔹was planned in the near future in 5 countries
🔸was not planned in 10 countries

#LTBI screening was predominantly for asylum seekers (n = 12) & refugees (n = 11)

https://t.co/mssFzRnxCt

[Cancer Immunology Research @CIR_AACR]

New Review: Immune-Guided Therapy of #COVID19 by Ferraccioli, Bronte et al.
https://t.co/RB5z7fKIxS
@EGremese @Deliagoletti2 @StefanoUgel #CIRReviewerStar ⭐

[delia goletti @Deliagoletti2]

La tubercolosi è una malattia prevenibile e curabile.
Tuttavia la mortalità nel 2020 è stata del 15%.
È importante fare azioni politiche, sanitarie, economiche congiunte per ridurre la diffusione e migliorare l'accesso alle cure.